dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· April 16, 2026

Disney Stock Price Prediction: Where Will The Stock be In 2027?

View original at finance.yahoo.com
“The sell-off was amplified by a 77.07% plunge in operating cash flow to $735 million, driven largely by accelerated tax payments tied to California wildfire disaster relief, reflecting a one-time timing item rather than any change in underlying business performance.”
Verbatim excerpt from the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • 84% of covering analysts rated bullish on Disney

    60% confidence
  • Management targeting a 10% SVOD operating margin for the full year FY2026

    60% confidence
  • Strong fundamental visibility and broad institutional support justifies 90% confidence level

    60% confidence
  • Management guided for double-digit adjusted EPS growth in both FY2026 and FY2027

    60% confidence
  • Disney price target is $116.32 with 15.06% upside from current price of $101.10

    60% confidence
  • Operating cash flow plunge was driven by accelerated tax payments tied to California wildfire disaster relief, reflecting a one-time timing item rather than any change in underlying business performance

    60% confidence
  • Disney stock rating is BUY with 90% confidence level

    60% confidence

Data points we hold from this source

The Walt Disney Company · stock price101.10 USD
The Walt Disney Company · experiences revenue10 USD
The Walt Disney Company · experiences operating income3.3 USD
The Walt Disney Company · eps1.63 USD
The Walt Disney Company · operating cash flow735 USD
The Walt Disney Company · streaming operating income450 USD
The Walt Disney Company · total streaming subscribers196 millions
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Disney Stock Price Prediction: Where Will The Stock be In 2027?: Source | Via News | fr.via.news